The Online Investor
Stock Buybacks
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Stock Buybacks

By The Online Investor Staff, updated Sat., Sep. 20, 7:56 AM

Slide #3. ICON Plc

$Amount Authorized: $100,000,000
Buyback Details: ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 million buyback of the Company's ordinary shares through open market acquisitions at an average price of $49.87. In addition, the Company announced a further program under which the Company can acquire (by way of redemption) up to an additional $100 million of its outstanding ordinary shares through open market share acquisitions.

Icon is a contract research organization (CRO), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. Co. specializes in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. Co. conducts clinical trials in all major therapeutic areas on a global basis. Co. provides Phase I - IV Clinical Trial Management, Drug Development Support Services, Data Management, Biostatistics, Central Laboratory, Imaging and Staff Contracting services.
Open the ICLR Page at The Online Investor »

Company Name:  Icon Plc
Sector:  Biotechnology
Number of ETFs Holding ICLR:  6
Total Market Value Held by ETFs:  $9.29M
Total Market Capitalization:  $3.50B
% of Market Cap. Held by ETFs:  0.27%

Open the ICLR Page at The Online Investor (in a new window) »

September 20, 2014    7:56 AM Eastern
Quotes delayed 20 minutes

Buy (3.46 out of 4)
70th percentile
(ranked higher than approx. 70% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Buybacks | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.